Michael Schwartz

Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200

Bruce J. Giantonio, Paul J. Catalano, Neal J. Meropol et al. · Journal of Clinical Oncology · 2007 · 2.3K citations

Medicine, Oncology, Pharmacotherapy +15

A case-series test of the interactive two-step model of lexical access: Evidence from picture naming☆

Michael Schwartz, Gary S. Dell, Nadine Martin et al. · Journal of Memory and Language · 2005 · 323 citations

Language Studies, Linguistics, Psycholinguistics +15

Semantic interference during blocked-cyclic naming: Evidence from aphasia☆

Tatiana T. Schnur, Michael Schwartz, Adelyn Brecher et al. · Journal of Memory and Language · 2005 · 322 citations

Social Sciences, Neuroscience, Psychology +9

Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200

Bruce J. Giantonio, Paul J. Catalano, Neal J. Meropol et al. · Journal of Clinical Oncology · 2023 · 163 citations

Medicine, Oncology, Pharmacotherapy +15

Dose-escalation trial of M195 labeled with iodine 131 for cytoreduction and marrow ablation in relapsed or refractory myeloid leukemias.

Michael Schwartz, Dennis Lovett, Arlene Redner et al. · Journal of Clinical Oncology · 1993 · 131 citations

Medicine, Hematology, Oncology +15